Industry Research Reports

Home > Reports > Medical Care > Recombinant Protein Reagents- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Recombinant Protein Reagents- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Care

Published Date: 2025-01-13

Pages: 135 Pages

Report ld: 3501971

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Recombinant Protein Reagents was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

North American market for Recombinant Protein Reagents was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Recombinant Protein Reagents was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Recombinant Protein Reagents was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Recombinant Protein Reagents include Abcam PLC, R&D Systems, Miltenyi Biotec, Merck KGaA, ThermoFisher Scientific, GE Healthcare, Lonza, Eurogentec (Kaneka Corporation), PeproTech, BPS Bioscience, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Recombinant Protein Reagents, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Recombinant Protein Reagents by region & country, by Type, and by Application.

The Recombinant Protein Reagents market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Protein Reagents.

MARKET SEGMENTATION

By Company

Abcam PLC
R&D Systems
Miltenyi Biotec
Merck KGaA
ThermoFisher Scientific
GE Healthcare
Lonza
Eurogentec (Kaneka Corporation)
PeproTech
BPS Bioscience
Reprocell
Abnova Corporation
GenScript Biotech Corporation
ProSpec Tany TechnoGene
Novoprotein
Sino Biological
ACROBiosystems Group

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others

Segment by Application

Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Recombinant Protein Reagents company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Recombinant Protein Reagents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Recombinant Protein Reagents in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Recombinant Protein Reagents Product Introduction

1.2 Global Recombinant Protein Reagents Market Size Forecast (2020-2031)

1.3 Recombinant Protein Reagents Market Trends & Drivers

1.3.1 Recombinant Protein Reagents Industry Trends

1.3.2 Recombinant Protein Reagents Market Drivers & Opportunity

1.3.3 Recombinant Protein Reagents Market Challenges

1.3.4 Recombinant Protein Reagents Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Recombinant Protein Reagents Players Revenue Ranking (2024)

2.2 Global Recombinant Protein Reagents Revenue by Company (2020-2025)

2.3 Key Companies Recombinant Protein Reagents Manufacturing Base Distribution and Headquarters

2.4 Key Companies Recombinant Protein Reagents Product Offered

2.5 Key Companies Time to Begin Mass Production of Recombinant Protein Reagents

2.6 Recombinant Protein Reagents Market Competitive Analysis

2.6.1 Recombinant Protein Reagents Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Recombinant Protein Reagents Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Protein Reagents as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Hormones

3.1.2 Growth Factors

3.1.3 Cytokines

3.1.4 Plasma Protein Factor

3.1.5 Recombinant Metabolic Enzymes

3.1.6 Immune Checkpoint Regulators

3.1.7 Others

3.2 Global Recombinant Protein Reagents Sales Value by Type

3.2.1 Global Recombinant Protein Reagents Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Recombinant Protein Reagents Sales Value, by Type (2020-2031)

3.2.3 Global Recombinant Protein Reagents Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Biopharmaceutical Companies

4.1.2 Academic and Research Institutes

4.1.3 Contract Research Organizations

4.2 Global Recombinant Protein Reagents Sales Value by Application

4.2.1 Global Recombinant Protein Reagents Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Recombinant Protein Reagents Sales Value, by Application (2020-2031)

4.2.3 Global Recombinant Protein Reagents Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global Recombinant Protein Reagents Sales Value by Region

5.1.1 Global Recombinant Protein Reagents Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Recombinant Protein Reagents Sales Value by Region (2020-2025)

5.1.3 Global Recombinant Protein Reagents Sales Value by Region (2026-2031)

5.1.4 Global Recombinant Protein Reagents Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Recombinant Protein Reagents Sales Value, 2020-2031

5.2.2 North America Recombinant Protein Reagents Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Recombinant Protein Reagents Sales Value, 2020-2031

5.3.2 Europe Recombinant Protein Reagents Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Recombinant Protein Reagents Sales Value, 2020-2031

5.4.2 Asia Pacific Recombinant Protein Reagents Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Recombinant Protein Reagents Sales Value, 2020-2031

5.5.2 South America Recombinant Protein Reagents Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Recombinant Protein Reagents Sales Value, 2020-2031

5.6.2 Middle East & Africa Recombinant Protein Reagents Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Recombinant Protein Reagents Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Recombinant Protein Reagents Sales Value, 2020-2031

6.3 United States

6.3.1 United States Recombinant Protein Reagents Sales Value, 2020-2031

6.3.2 United States Recombinant Protein Reagents Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Recombinant Protein Reagents Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Recombinant Protein Reagents Sales Value, 2020-2031

6.4.2 Europe Recombinant Protein Reagents Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Recombinant Protein Reagents Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Recombinant Protein Reagents Sales Value, 2020-2031

6.5.2 China Recombinant Protein Reagents Sales Value by Type (%), 2024 VS 2031

6.5.3 China Recombinant Protein Reagents Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Recombinant Protein Reagents Sales Value, 2020-2031

6.6.2 Japan Recombinant Protein Reagents Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Recombinant Protein Reagents Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Recombinant Protein Reagents Sales Value, 2020-2031

6.7.2 South Korea Recombinant Protein Reagents Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Recombinant Protein Reagents Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Recombinant Protein Reagents Sales Value, 2020-2031

6.8.2 Southeast Asia Recombinant Protein Reagents Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Recombinant Protein Reagents Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Recombinant Protein Reagents Sales Value, 2020-2031

6.9.2 India Recombinant Protein Reagents Sales Value by Type (%), 2024 VS 2031

6.9.3 India Recombinant Protein Reagents Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Abcam PLC

7.1.1 Abcam PLC Profile

7.1.2 Abcam PLC Main Business

7.1.3 Abcam PLC Recombinant Protein Reagents Products, Services and Solutions

7.1.4 Abcam PLC Recombinant Protein Reagents Revenue (US$ Million) & (2020-2025)

7.1.5 Abcam PLC Recent Developments

7.2 R&D Systems

7.2.1 R&D Systems Profile

7.2.2 R&D Systems Main Business

7.2.3 R&D Systems Recombinant Protein Reagents Products, Services and Solutions

7.2.4 R&D Systems Recombinant Protein Reagents Revenue (US$ Million) & (2020-2025)

7.2.5 R&D Systems Recent Developments

7.3 Miltenyi Biotec

7.3.1 Miltenyi Biotec Profile

7.3.2 Miltenyi Biotec Main Business

7.3.3 Miltenyi Biotec Recombinant Protein Reagents Products, Services and Solutions

7.3.4 Miltenyi Biotec Recombinant Protein Reagents Revenue (US$ Million) & (2020-2025)

7.3.5 Miltenyi Biotec Recent Developments

7.4 Merck KGaA

7.4.1 Merck KGaA Profile

7.4.2 Merck KGaA Main Business

7.4.3 Merck KGaA Recombinant Protein Reagents Products, Services and Solutions

7.4.4 Merck KGaA Recombinant Protein Reagents Revenue (US$ Million) & (2020-2025)

7.4.5 Merck KGaA Recent Developments

7.5 ThermoFisher Scientific

7.5.1 ThermoFisher Scientific Profile

7.5.2 ThermoFisher Scientific Main Business

7.5.3 ThermoFisher Scientific Recombinant Protein Reagents Products, Services and Solutions

7.5.4 ThermoFisher Scientific Recombinant Protein Reagents Revenue (US$ Million) & (2020-2025)

7.5.5 ThermoFisher Scientific Recent Developments

7.6 GE Healthcare

7.6.1 GE Healthcare Profile

7.6.2 GE Healthcare Main Business

7.6.3 GE Healthcare Recombinant Protein Reagents Products, Services and Solutions

7.6.4 GE Healthcare Recombinant Protein Reagents Revenue (US$ Million) & (2020-2025)

7.6.5 GE Healthcare Recent Developments

7.7 Lonza

7.7.1 Lonza Profile

7.7.2 Lonza Main Business

7.7.3 Lonza Recombinant Protein Reagents Products, Services and Solutions

7.7.4 Lonza Recombinant Protein Reagents Revenue (US$ Million) & (2020-2025)

7.7.5 Lonza Recent Developments

7.8 Eurogentec (Kaneka Corporation)

7.8.1 Eurogentec (Kaneka Corporation) Profile

7.8.2 Eurogentec (Kaneka Corporation) Main Business

7.8.3 Eurogentec (Kaneka Corporation) Recombinant Protein Reagents Products, Services and Solutions

7.8.4 Eurogentec (Kaneka Corporation) Recombinant Protein Reagents Revenue (US$ Million) & (2020-2025)

7.8.5 Eurogentec (Kaneka Corporation) Recent Developments

7.9 PeproTech

7.9.1 PeproTech Profile

7.9.2 PeproTech Main Business

7.9.3 PeproTech Recombinant Protein Reagents Products, Services and Solutions

7.9.4 PeproTech Recombinant Protein Reagents Revenue (US$ Million) & (2020-2025)

7.9.5 PeproTech Recent Developments

7.10 BPS Bioscience

7.10.1 BPS Bioscience Profile

7.10.2 BPS Bioscience Main Business

7.10.3 BPS Bioscience Recombinant Protein Reagents Products, Services and Solutions

7.10.4 BPS Bioscience Recombinant Protein Reagents Revenue (US$ Million) & (2020-2025)

7.10.5 BPS Bioscience Recent Developments

7.11 Reprocell

7.11.1 Reprocell Profile

7.11.2 Reprocell Main Business

7.11.3 Reprocell Recombinant Protein Reagents Products, Services and Solutions

7.11.4 Reprocell Recombinant Protein Reagents Revenue (US$ Million) & (2020-2025)

7.11.5 Reprocell Recent Developments

7.12 Abnova Corporation

7.12.1 Abnova Corporation Profile

7.12.2 Abnova Corporation Main Business

7.12.3 Abnova Corporation Recombinant Protein Reagents Products, Services and Solutions

7.12.4 Abnova Corporation Recombinant Protein Reagents Revenue (US$ Million) & (2020-2025)

7.12.5 Abnova Corporation Recent Developments

7.13 GenScript Biotech Corporation

7.13.1 GenScript Biotech Corporation Profile

7.13.2 GenScript Biotech Corporation Main Business

7.13.3 GenScript Biotech Corporation Recombinant Protein Reagents Products, Services and Solutions

7.13.4 GenScript Biotech Corporation Recombinant Protein Reagents Revenue (US$ Million) & (2020-2025)

7.13.5 GenScript Biotech Corporation Recent Developments

7.14 ProSpec Tany TechnoGene

7.14.1 ProSpec Tany TechnoGene Profile

7.14.2 ProSpec Tany TechnoGene Main Business

7.14.3 ProSpec Tany TechnoGene Recombinant Protein Reagents Products, Services and Solutions

7.14.4 ProSpec Tany TechnoGene Recombinant Protein Reagents Revenue (US$ Million) & (2020-2025)

7.14.5 ProSpec Tany TechnoGene Recent Developments

7.15 Novoprotein

7.15.1 Novoprotein Profile

7.15.2 Novoprotein Main Business

7.15.3 Novoprotein Recombinant Protein Reagents Products, Services and Solutions

7.15.4 Novoprotein Recombinant Protein Reagents Revenue (US$ Million) & (2020-2025)

7.15.5 Novoprotein Recent Developments

7.16 Sino Biological

7.16.1 Sino Biological Profile

7.16.2 Sino Biological Main Business

7.16.3 Sino Biological Recombinant Protein Reagents Products, Services and Solutions

7.16.4 Sino Biological Recombinant Protein Reagents Revenue (US$ Million) & (2020-2025)

7.16.5 Sino Biological Recent Developments

7.17 ACROBiosystems Group

7.17.1 ACROBiosystems Group Profile

7.17.2 ACROBiosystems Group Main Business

7.17.3 ACROBiosystems Group Recombinant Protein Reagents Products, Services and Solutions

7.17.4 ACROBiosystems Group Recombinant Protein Reagents Revenue (US$ Million) & (2020-2025)

7.17.5 ACROBiosystems Group Recent Developments

8 Industry Chain Analysis

8.1 Recombinant Protein Reagents Industrial Chain

8.2 Recombinant Protein Reagents Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Recombinant Protein Reagents Sales Model

8.5.2 Sales Channel

8.5.3 Recombinant Protein Reagents Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Recombinant Protein Reagents Market Trends

Table 2. Recombinant Protein Reagents Market Drivers & Opportunity

Table 3. Recombinant Protein Reagents Market Challenges

Table 4. Recombinant Protein Reagents Market Restraints

Table 5. Global Recombinant Protein Reagents Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Recombinant Protein Reagents Revenue Market Share by Company (2020-2025)

Table 7. Key Companies Recombinant Protein Reagents Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Recombinant Protein Reagents Product Type

Table 9. Key Companies Time to Begin Mass Production of Recombinant Protein Reagents

Table 10. Global Recombinant Protein Reagents Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Protein Reagents as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Recombinant Protein Reagents Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global Recombinant Protein Reagents Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global Recombinant Protein Reagents Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global Recombinant Protein Reagents Sales Market Share in Value by Type (2020-2025)

Table 17. Global Recombinant Protein Reagents Sales Market Share in Value by Type (2026-2031)

Table 18. Global Recombinant Protein Reagents Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Recombinant Protein Reagents Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global Recombinant Protein Reagents Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global Recombinant Protein Reagents Sales Market Share in Value by Application (2020-2025)

Table 22. Global Recombinant Protein Reagents Sales Market Share in Value by Application (2026-2031)

Table 23. Global Recombinant Protein Reagents Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global Recombinant Protein Reagents Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global Recombinant Protein Reagents Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global Recombinant Protein Reagents Sales Value by Region (2020-2025) & (%)

Table 27. Global Recombinant Protein Reagents Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions Recombinant Protein Reagents Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions Recombinant Protein Reagents Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions Recombinant Protein Reagents Sales Value, (2026-2031) & (US$ Million)

Table 31. Abcam PLC Basic Information List

Table 32. Abcam PLC Description and Business Overview

Table 33. Abcam PLC Recombinant Protein Reagents Products, Services and Solutions

Table 34. Revenue (US$ Million) in Recombinant Protein Reagents Business of Abcam PLC (2020-2025)

Table 35. Abcam PLC Recent Developments

Table 36. R&D Systems Basic Information List

Table 37. R&D Systems Description and Business Overview

Table 38. R&D Systems Recombinant Protein Reagents Products, Services and Solutions

Table 39. Revenue (US$ Million) in Recombinant Protein Reagents Business of R&D Systems (2020-2025)

Table 40. R&D Systems Recent Developments

Table 41. Miltenyi Biotec Basic Information List

Table 42. Miltenyi Biotec Description and Business Overview

Table 43. Miltenyi Biotec Recombinant Protein Reagents Products, Services and Solutions

Table 44. Revenue (US$ Million) in Recombinant Protein Reagents Business of Miltenyi Biotec (2020-2025)

Table 45. Miltenyi Biotec Recent Developments

Table 46. Merck KGaA Basic Information List

Table 47. Merck KGaA Description and Business Overview

Table 48. Merck KGaA Recombinant Protein Reagents Products, Services and Solutions

Table 49. Revenue (US$ Million) in Recombinant Protein Reagents Business of Merck KGaA (2020-2025)

Table 50. Merck KGaA Recent Developments

Table 51. ThermoFisher Scientific Basic Information List

Table 52. ThermoFisher Scientific Description and Business Overview

Table 53. ThermoFisher Scientific Recombinant Protein Reagents Products, Services and Solutions

Table 54. Revenue (US$ Million) in Recombinant Protein Reagents Business of ThermoFisher Scientific (2020-2025)

Table 55. ThermoFisher Scientific Recent Developments

Table 56. GE Healthcare Basic Information List

Table 57. GE Healthcare Description and Business Overview

Table 58. GE Healthcare Recombinant Protein Reagents Products, Services and Solutions

Table 59. Revenue (US$ Million) in Recombinant Protein Reagents Business of GE Healthcare (2020-2025)

Table 60. GE Healthcare Recent Developments

Table 61. Lonza Basic Information List

Table 62. Lonza Description and Business Overview

Table 63. Lonza Recombinant Protein Reagents Products, Services and Solutions

Table 64. Revenue (US$ Million) in Recombinant Protein Reagents Business of Lonza (2020-2025)

Table 65. Lonza Recent Developments

Table 66. Eurogentec (Kaneka Corporation) Basic Information List

Table 67. Eurogentec (Kaneka Corporation) Description and Business Overview

Table 68. Eurogentec (Kaneka Corporation) Recombinant Protein Reagents Products, Services and Solutions

Table 69. Revenue (US$ Million) in Recombinant Protein Reagents Business of Eurogentec (Kaneka Corporation) (2020-2025)

Table 70. Eurogentec (Kaneka Corporation) Recent Developments

Table 71. PeproTech Basic Information List

Table 72. PeproTech Description and Business Overview

Table 73. PeproTech Recombinant Protein Reagents Products, Services and Solutions

Table 74. Revenue (US$ Million) in Recombinant Protein Reagents Business of PeproTech (2020-2025)

Table 75. PeproTech Recent Developments

Table 76. BPS Bioscience Basic Information List

Table 77. BPS Bioscience Description and Business Overview

Table 78. BPS Bioscience Recombinant Protein Reagents Products, Services and Solutions

Table 79. Revenue (US$ Million) in Recombinant Protein Reagents Business of BPS Bioscience (2020-2025)

Table 80. BPS Bioscience Recent Developments

Table 81. Reprocell Basic Information List

Table 82. Reprocell Description and Business Overview

Table 83. Reprocell Recombinant Protein Reagents Products, Services and Solutions

Table 84. Revenue (US$ Million) in Recombinant Protein Reagents Business of Reprocell (2020-2025)

Table 85. Reprocell Recent Developments

Table 86. Abnova Corporation Basic Information List

Table 87. Abnova Corporation Description and Business Overview

Table 88. Abnova Corporation Recombinant Protein Reagents Products, Services and Solutions

Table 89. Revenue (US$ Million) in Recombinant Protein Reagents Business of Abnova Corporation (2020-2025)

Table 90. Abnova Corporation Recent Developments

Table 91. GenScript Biotech Corporation Basic Information List

Table 92. GenScript Biotech Corporation Description and Business Overview

Table 93. GenScript Biotech Corporation Recombinant Protein Reagents Products, Services and Solutions

Table 94. Revenue (US$ Million) in Recombinant Protein Reagents Business of GenScript Biotech Corporation (2020-2025)

Table 95. GenScript Biotech Corporation Recent Developments

Table 96. ProSpec Tany TechnoGene Basic Information List

Table 97. ProSpec Tany TechnoGene Description and Business Overview

Table 98. ProSpec Tany TechnoGene Recombinant Protein Reagents Products, Services and Solutions

Table 99. Revenue (US$ Million) in Recombinant Protein Reagents Business of ProSpec Tany TechnoGene (2020-2025)

Table 100. ProSpec Tany TechnoGene Recent Developments

Table 101. Novoprotein Basic Information List

Table 102. Novoprotein Description and Business Overview

Table 103. Novoprotein Recombinant Protein Reagents Products, Services and Solutions

Table 104. Revenue (US$ Million) in Recombinant Protein Reagents Business of Novoprotein (2020-2025)

Table 105. Novoprotein Recent Developments

Table 106. Sino Biological Basic Information List

Table 107. Sino Biological Description and Business Overview

Table 108. Sino Biological Recombinant Protein Reagents Products, Services and Solutions

Table 109. Revenue (US$ Million) in Recombinant Protein Reagents Business of Sino Biological (2020-2025)

Table 110. Sino Biological Recent Developments

Table 111. ACROBiosystems Group Basic Information List

Table 112. ACROBiosystems Group Description and Business Overview

Table 113. ACROBiosystems Group Recombinant Protein Reagents Products, Services and Solutions

Table 114. Revenue (US$ Million) in Recombinant Protein Reagents Business of ACROBiosystems Group (2020-2025)

Table 115. ACROBiosystems Group Recent Developments

Table 116. Key Raw Materials Lists

Table 117. Raw Materials Key Suppliers Lists

Table 118. Recombinant Protein Reagents Downstream Customers

Table 119. Recombinant Protein Reagents Distributors List

Table 120. Research Programs/Design for This Report

Table 121. Key Data Information from Secondary Sources

Table 122. Key Data Information from Primary Sources

Table 123. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Recombinant Protein Reagents Product Picture

Figure 2. Global Recombinant Protein Reagents Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Recombinant Protein Reagents Sales Value (2020-2031) & (US$ Million)

Figure 4. Recombinant Protein Reagents Report Years Considered

Figure 5. Global Recombinant Protein Reagents Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Recombinant Protein Reagents Revenue in 2024

Figure 7. Recombinant Protein Reagents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Hormones Picture

Figure 9. Growth Factors Picture

Figure 10. Cytokines Picture

Figure 11. Plasma Protein Factor Picture

Figure 12. Recombinant Metabolic Enzymes Picture

Figure 13. Immune Checkpoint Regulators Picture

Figure 14. Others Picture

Figure 15. Global Recombinant Protein Reagents Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 16. Global Recombinant Protein Reagents Sales Value Market Share by Type, 2024 & 2031

Figure 17. Product Picture of Biopharmaceutical Companies

Figure 18. Product Picture of Academic and Research Institutes

Figure 19. Product Picture of Contract Research Organizations

Figure 20. Global Recombinant Protein Reagents Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 21. Global Recombinant Protein Reagents Sales Value Market Share by Application, 2024 & 2031

Figure 22. North America Recombinant Protein Reagents Sales Value (2020-2031) & (US$ Million)

Figure 23. North America Recombinant Protein Reagents Sales Value by Country (%), 2024 VS 2031

Figure 24. Europe Recombinant Protein Reagents Sales Value, (2020-2031) & (US$ Million)

Figure 25. Europe Recombinant Protein Reagents Sales Value by Country (%), 2024 VS 2031

Figure 26. Asia Pacific Recombinant Protein Reagents Sales Value, (2020-2031) & (US$ Million)

Figure 27. Asia Pacific Recombinant Protein Reagents Sales Value by Region (%), 2024 VS 2031

Figure 28. South America Recombinant Protein Reagents Sales Value, (2020-2031) & (US$ Million)

Figure 29. South America Recombinant Protein Reagents Sales Value by Country (%), 2024 VS 2031

Figure 30. Middle East & Africa Recombinant Protein Reagents Sales Value, (2020-2031) & (US$ Million)

Figure 31. Middle East & Africa Recombinant Protein Reagents Sales Value by Country (%), 2024 VS 2031

Figure 32. Key Countries/Regions Recombinant Protein Reagents Sales Value (%), (2020-2031)

Figure 33. United States Recombinant Protein Reagents Sales Value, (2020-2031) & (US$ Million)

Figure 34. United States Recombinant Protein Reagents Sales Value by Type (%), 2024 VS 2031

Figure 35. United States Recombinant Protein Reagents Sales Value by Application (%), 2024 VS 2031

Figure 36. Europe Recombinant Protein Reagents Sales Value, (2020-2031) & (US$ Million)

Figure 37. Europe Recombinant Protein Reagents Sales Value by Type (%), 2024 VS 2031

Figure 38. Europe Recombinant Protein Reagents Sales Value by Application (%), 2024 VS 2031

Figure 39. China Recombinant Protein Reagents Sales Value, (2020-2031) & (US$ Million)

Figure 40. China Recombinant Protein Reagents Sales Value by Type (%), 2024 VS 2031

Figure 41. China Recombinant Protein Reagents Sales Value by Application (%), 2024 VS 2031

Figure 42. Japan Recombinant Protein Reagents Sales Value, (2020-2031) & (US$ Million)

Figure 43. Japan Recombinant Protein Reagents Sales Value by Type (%), 2024 VS 2031

Figure 44. Japan Recombinant Protein Reagents Sales Value by Application (%), 2024 VS 2031

Figure 45. South Korea Recombinant Protein Reagents Sales Value, (2020-2031) & (US$ Million)

Figure 46. South Korea Recombinant Protein Reagents Sales Value by Type (%), 2024 VS 2031

Figure 47. South Korea Recombinant Protein Reagents Sales Value by Application (%), 2024 VS 2031

Figure 48. Southeast Asia Recombinant Protein Reagents Sales Value, (2020-2031) & (US$ Million)

Figure 49. Southeast Asia Recombinant Protein Reagents Sales Value by Type (%), 2024 VS 2031

Figure 50. Southeast Asia Recombinant Protein Reagents Sales Value by Application (%), 2024 VS 2031

Figure 51. India Recombinant Protein Reagents Sales Value, (2020-2031) & (US$ Million)

Figure 52. India Recombinant Protein Reagents Sales Value by Type (%), 2024 VS 2031

Figure 53. India Recombinant Protein Reagents Sales Value by Application (%), 2024 VS 2031

Figure 54. Recombinant Protein Reagents Industrial Chain

Figure 55. Recombinant Protein Reagents Manufacturing Cost Structure

Figure 56. Channels of Distribution (Direct Sales, and Distribution)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Recombinant Protein Reagents market? zhanKai

The top companies in the global Recombinant Protein Reagents market are Abcam PLC、R&D Systems、Miltenyi Biotec.

Related Reports

Global Recombinant Protein Reagents Market Research Report 2025
The global market for Recombinant Protein Reagents was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 96
USD 2900.00
(Single User License)
Global Recombinant Protein Reagents Market Insights, Forecast to 2030
Market Analysis and Insights: Global Recombinant Protein Reagents Market
Published Date: 2024-04-15
Pages: 112
USD 4900.00
(Single User License)
Global Recombinant Protein Reagents Market Research Report 2024
The global Recombinant Protein Reagents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-18
Pages: 97
USD 2900.00
(Single User License)

Global Recombinant Protein Reagents Market Research Report 2025
The global market for Recombinant Protein Reagents was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 96
USD 2900.00 (Single User License)
Global Recombinant Protein Reagents Market Insights, Forecast to 2030
Market Analysis and Insights: Global Recombinant Protein Reagents Market
Published: 2024-04-15
Pages: 112
USD 4900.00 (Single User License)
Global Recombinant Protein Reagents Market Research Report 2024
The global Recombinant Protein Reagents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-18
Pages: 97
USD 2900.00 (Single User License)